Current status of the field of obesity

Trends in Endocrinology and Metabolism

Volumn 25, Issue 6, 2014, Pages 283-284

  Atkinson, Richard L ^a,b  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^b Obetech Obesity Research Center   (United States)

Author keywords

Adipose tissue; Drugs; Energy balance; Energy expenditure; Gut hormones; Obesity surgery

Indexed keywords

BODY COMPOSITION; CALORIC INTAKE; DIET RESTRICTION; ENERGY EXPENDITURE; EPIGENETICS; HEALTH CARE QUALITY; HEREDITY; HORMONE DETERMINATION; HUMAN; LIFESTYLE MODIFICATION; LIPID STORAGE; NONHUMAN; NOTE; OBESITY; PRACTICE GUIDELINE; PRIORITY JOURNAL; WEIGHT CHANGE; WEIGHT REDUCTION; ADIPOSE TISSUE; BARIATRIC SURGERY; DRUG EFFECTS; ENERGY METABOLISM; METABOLISM;

ANTIDIABETIC AGENT;

ADIPOSE TISSUE; BARIATRIC SURGERY; ENERGY METABOLISM; HUMANS; HYPOGLYCEMIC AGENTS; OBESITY;

EID: 84901834303     PISSN: 10432760     EISSN: 18793061     Source Type: Journal    
DOI: 10.1016/j.tem.2014.03.003     Document Type: Note

References (14)

1. Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes. N. Engl. J. Med. 2013, 369:145-154. Look AHEAD Research Group.
2. Stunkard A.J., McLaren-Hume M. The results of treatment for obesity. JAMA 1959, 103:79-85.
3. Wadden T.A., et al. A two-year randomized trial of obesity treatment in primary care practice. N. Engl. J. Med. 2011, 365:1969-1979.
4. Galgani J., Ravussin E. Energy metabolism, fuel selection and body weight regulation. Int. J. Obes. (Lond.) 2008, 32(Suppl. 7):S109-S119.
5. Keys A., et al. The Biology of Human Starvation 1950, University of Minnesota Press.
6. Rosenbaum M., Leibel R.L. Adaptive thermogenesis in humans. Int. J. Obes. (Lond.) 2010, 34(Suppl. 1):S47-S55.
7. Munro J.F., et al. Comparison of continuous and intermittent anorectic therapy in obesity. Br. Med. J. 1968, 1:352-354.
8. Keesey R.E. Physiological regulation of body weight and the issue of obesity. Med. Clin. North Am. 1989, 73:15-27.
9. Yanovski S.Z., Yanovski J.A. Long-term drug treatment for obesity: a systematic and clinical review. JAMA 2014, 311:74-86.
10. Hendricks E.J., et al. Addiction potential of phentermine prescribed during long-term treatment of obesity. Int. J. Obes. (Lond.) 2014, 38:292-298.
11. Troke R.C., et al. The future role of gut hormones in the treatment of obesity. Ther. Adv. Chronic Dis. 2014, 5:4-14.
12. Atkinson R.L. Human adenovirus-36 and childhood obesity. Int. J. Pediatr. Obes. 2011, 6(Suppl. 1):2-6.
13. Atkinson R.L., et al. Human adenovirus-36 is associated with increased body weight and paradoxical reduction of serum lipids. Int. J. Obes. (Lond.) 2005, 29:281-286.
14. Aldhoon-Hainerová I., et al. Clinical and laboratory characteristics of 1179 Czech adolescents evaluated for antibodies to human adenovirus 36. Int. J. Obes. (Lond.) 2014, 38:285-291.